BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 27496936)

  • 21. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis.
    Caldeira D; Rodrigues FB; Barra M; Santos AT; de Abreu D; Gonçalves N; Pinto FJ; Ferreira JJ; Costa J
    Heart; 2015 Aug; 101(15):1204-11. PubMed ID: 26037103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive function and anticoagulation control in patients with atrial fibrillation.
    Flaker GC; Pogue J; Yusuf S; Pfeffer MA; Goldhaber SZ; Granger CB; Anand IS; Hart R; Connolly SJ;
    Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):277-83. PubMed ID: 20233976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review.
    Udompanich S; Lip GY; Apostolakis S; Lane DA
    QJM; 2013 Sep; 106(9):795-802. PubMed ID: 23737509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between atrial fibrillation and cognitive decline in individuals aged 80 and older.
    Proietti M; Recchia A; Riva E; Lucca U; Tettamanti M; Mannucci PM; Nobili A
    Eur J Intern Med; 2017 Dec; 46():6-10. PubMed ID: 28803036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry.
    Lip GY; Laroche C; Popescu MI; Rasmussen LH; Vitali-Serdoz L; Dan GA; Kalarus Z; Crijns HJ; Oliveira MM; Tavazzi L; Maggioni AP; Boriani G
    Europace; 2015 Dec; 17(12):1777-86. PubMed ID: 26321406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation.
    Dzeshka MS; Lip GY
    Heart Fail Clin; 2016 Apr; 12(2):257-71. PubMed ID: 26968670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
    Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
    Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
    Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Underuse of Anticoagulation in Older Patients with Atrial Fibrillation and CHADS
    Henrard S; Vandenabeele C; Marien S; Boland B; Dalleur O
    Drugs Aging; 2017 Nov; 34(11):841-850. PubMed ID: 29086350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimising stroke prevention in patients with atrial fibrillation: application of the GRASP-AF audit tool in a UK general practice cohort.
    Shantsila E; Wolff A; Lip GY; Lane DA
    Br J Gen Pract; 2015 Jan; 65(630):e16-23. PubMed ID: 25548312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Impact of different antithrombotic therapy strategy on prognosis in coronary heart disease patients combining with atrial fibrillation: a meta analysis].
    Yuan C; Zhong L; Huang RC
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jun; 45(6):526-535. PubMed ID: 28648031
    [No Abstract]   [Full Text] [Related]  

  • 33. Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.
    Gullón A; Suárez C; Díez-Manglano J; Formiga F; Cepeda JM; Pose A; Camafort M; Castiella J; Rovira E; Mostaza JM;
    Med Clin (Barc); 2017 Mar; 148(5):204-210. PubMed ID: 27993408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antithrombotic management of atrial fibrillation for stroke prevention in older people.
    Tong DC; Albers GW
    Clin Geriatr Med; 1999 Nov; 15(4):645-62. PubMed ID: 10499928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation in atrial fibrillation and cognitive decline: A systematic review and meta-analysis.
    Zeng D; Jiang C; Su C; Tan Y; Wu J
    Medicine (Baltimore); 2019 Feb; 98(7):e14499. PubMed ID: 30762777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
    Duerschmied D; Brachmann J; Darius H; Frey N; Katus HA; Rottbauer W; Schäfer A; Thiele H; Bode C; Zeymer U
    Clin Res Cardiol; 2018 Jul; 107(7):533-538. PubMed ID: 29679144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of atrial fibrillation and outcomes in older long-term care residents: a systematic review.
    Ritchie LA; Oke OB; Harrison SL; Rodgers SE; Lip GYH; Lane DA
    Age Ageing; 2021 May; 50(3):744-757. PubMed ID: 33951148
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial fibrillation and incidence of dementia: a systematic review and meta-analysis.
    Kwok CS; Loke YK; Hale R; Potter JF; Myint PK
    Neurology; 2011 Mar; 76(10):914-22. PubMed ID: 21383328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.
    Lip GY
    Thromb Haemost; 2010 Apr; 103(4):683-5. PubMed ID: 20135056
    [No Abstract]   [Full Text] [Related]  

  • 40. Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27803042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.